FDA-approved vs unapproved GLP-1 products: what patients should know

FDA-approved means reviewed for a specific product and use

An FDA-approved drug has been reviewed by FDA for safety, effectiveness, quality, labeling, and manufacturing for its approved use. That does not mean every product advertised online with a similar ingredient has the same status.

Unapproved products can create real risk

FDA has warned about unapproved GLP-1 products used for weight loss, including concerns about dosing errors, counterfeit drugs, fraudulent compounded products, and active pharmaceutical ingredients from unverified sources.

• Counterfeit products may contain too little, too much, or none of the active ingredient.
• Some products may use ingredients or forms that are not the approved product.
• Online sellers may blur the difference between FDA-approved medications, compounded products, and lookalike products.

The supply chain matters

FDA created a Green List import alert to help stop GLP-1 active pharmaceutical ingredients with potential quality concerns from entering the U.S. supply chain. That is a signal to ask direct sourcing questions.

Match the label to a real pharmacy

FDA's June 2026 update says some fraudulent compounded semaglutide and tirzepatide products have been labeled as if they came from pharmacies that did not make them or as if they used incorrect pharmacy names. That turns pharmacy verification into a practical safety step, not paperwork.

• Ask for the dispensing pharmacy's legal name before payment.
• Check that the label, receipt, prescriber, and pharmacy contact information match what the provider told you.
• Call the pharmacy or clinician before using a product if labeling, packaging, or sourcing is unclear.

Questions before you pay

Ask the provider to name the exact product, active ingredient, pharmacy, source, dose form, and whether it is FDA-approved for the discussed use. If the answer is vague, do not rush.

A directory should not hide this distinction

GLP Clinic Finder should clearly separate FDA-approved products, compounded products, and unknown sourcing in future provider profiles so users can compare transparently.